Clinical Measures of Chronic Urticaria - 20/12/17
, Frank Siebenhaar, MD, Tomasz Hawro, MD, Sabine Altrichter, MD, Nicole Schoepke, MD, Marcus Maurer, MDRésumé |
The use of standardized, valid, and reliable clinical measures is an important element in modern patient management, particularly in diseases that are not objectively assessable and are associated with a high disease burden. Chronic urticaria is such a disorder for which several new and well-developed clinical measures became available. These measures comprise tools to assess disease activity, disease control, and health-related quality-of-life impairment. This review provides an overview of the currently available clinical measures for chronic urticaria. In addition, it provides information on their strengths and limitations and how to best use them and evaluate their results.
Le texte complet de cet article est disponible en PDF.Keywords : Urticaria, Angioedema, Patient reported outcome, Disease activity, Disease control, Quality of life
Plan
| Conflicts of Interest: K. Weller is or recently was a speaker, investigator, and/or consultant for Dr R. Pfleger, Essex pharma (now MSD), FAES, Novartis, Shire, UCB, Uriach, Viropharma, and Moxie. F. Siebenhaar is or recently was a speaker, grant recipient, and/or advisor for BioCryst, Novartis, Moxie, Patara, and Uriach. T. Hawro is or recently was a speaker for Moxie. S. Altrichter is or recently was a speaker for Moxie. N. Schoepke is or recently was a speaker for Moxie. M. Maurer is or recently was a speaker, grant recipient, and/or advisor for BioCryst, Courage & Khazaka, FAES, Genentech, Moxie, Novartis, Sanofi, Shire, and/or Uriach. |
|
| Financial Support and Sponsorship: None. |
Vol 37 - N° 1
P. 35-49 - février 2017 Retour au numéro
Article précédent
- Differential Diagnosis of Atopic Dermatitis
- Meagan Barrett, Minnelly Luu
- Current and Future Biomarkers in Atopic Dermatitis
- Judith L. Thijs, Marjolein S. de Bruin-Weller, DirkJan Hijnen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?